Fleetyr | $750,000 | (Sep 25, 2025)
enaDyne | $8,220,207 | (Sep 25, 2025)
OnFinance AI | $4,200,000 | (Sep 25, 2025)
Certified by Founder
Lodge
Avenue Therapeutics
start up
United States
- New York, NY
- 13/12/2021
- Unknown
- $2,000,000
Avenue Therapeutics, Inc. (NASDAQ: ATXI), a Fortress Biotech (NASDAQ: FBIO) Company, is a specialty pharmaceutical company.
Please be aware of Recruiting Fraud: https://www.avenuetx.com/beware-of-recruiting-fraud/
- Industry Biotechnology Research
- Website https://www.avenuetx.com/
- LinkedIn https://www.linkedin.com/company/avenue-therapeutics/
Related People
Lucy LuFounder
United States -
New York City Metropolitan Area
I am an executive of a development-stage biotech company. Prior to working in the biotech industry, I was a senior equity analyst covering small- to mid-cap biotechnology companies. My expertise includes strategic planning, clinical development, regulatory strategy, business development, biotech equity valuation, investor relations and capital markets.
AmplifyMD | $20,000,000 | (Sep 25, 2025)
amplio | $11,100,000 | (Sep 25, 2025)
Synthesized | $20,000,000 | (Sep 25, 2025)
FYR Bio | $8,000,000 | (Sep 25, 2025)
yasp | $5,000,000 | (Sep 25, 2025)
BizzyCar | $20,000,000 | (Sep 25, 2025)
Emergent | $23,000,000 | (Sep 25, 2025)
Lifeguard | $1,300,000 | (Sep 25, 2025)
Sparrow Pharmaceuticals, Inc. | $95,000,000 | (Sep 25, 2025)